WindMIL Therapeutics’ Don Hayden, Kim Noonan, Monil Shah, and Patrick Dougherty will be in San Francisco for JPMorgan week to meet with potential and existing investors and partners.
Kimberly Noonan, WindMIL’s EVP, CSO and Co-Founder will participate in the 2019 Association for Value-Based Cancer Care (AVBCC) Summit on Thursday, October 17th at the New York Athletic Club in NYC. Kim will be joining the panel entitled “Tracking the Innovative Value of CAR, T-cell, NK Cell, Gamma Delta Cells, and Gene Editing Therapies”.
Bethesda North Marriott Hotel & Conference Center — Kim Noonan will be participating in the panel “Changing the Landscape for Cell and Gene Therapy”
WindMIL Therapeutics will present at the Cell & Gene Meeting on the Mesa in Carlsbad, CA on October 3rd, 2019.